Skip to content

Clinical trials

Atherosclerosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Canada Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20036
20041
20055
20063
20071
20085
20093
20104
20113
20124
20131
20144
20157
20165
20172
20183
20195
20204
20213
20226
20232
20243
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Unknown status11
Recruiting10
Terminated8
Active, not recruiting6
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
GlaxoSmithKline4
Novartis Pharmaceuticals4
Sunnybrook Health Sciences Centre4
AstraZeneca3
Boston Scientific Corporation3
Dr. Amer Johri3
Eli Lilly and Company3
Laval University3
University of Alberta3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis92
Cardiovascular Diseases30
Coronary Artery Disease17
Diabetes Mellitus10
Myocardial Infarction10
Coronary Disease8
Heart Diseases8
Acute Coronary Syndrome6
Diabetes Mellitus, Type 26
Hypercholesterolemia6

Trials

Showing 26 to 50 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.